Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 15.44 USD 3.14% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Progyny Inc?
Write Note

Progyny Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Progyny Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Progyny Inc
NASDAQ:PGNY
Operating Income
$65.5m
CAGR 3-Years
25%
CAGR 5-Years
52%
CAGR 10-Years
N/A
UnitedHealth Group Inc
NYSE:UNH
Operating Income
$32.2B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
12%
Centene Corp
NYSE:CNC
Operating Income
$3B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
24%
Molina Healthcare Inc
NYSE:MOH
Operating Income
$1.6B
CAGR 3-Years
19%
CAGR 5-Years
8%
CAGR 10-Years
33%
Humana Inc
NYSE:HUM
Operating Income
$3.5B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
6%
Elevance Health Inc
NYSE:ELV
Operating Income
$9.2B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
7%
No Stocks Found

Progyny Inc
Glance View

Market Cap
1.4B USD
Industry
Health Care

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

PGNY Intrinsic Value
38.38 USD
Undervaluation 60%
Intrinsic Value
Price

See Also

What is Progyny Inc's Operating Income?
Operating Income
65.5m USD

Based on the financial report for Sep 30, 2024, Progyny Inc's Operating Income amounts to 65.5m USD.

What is Progyny Inc's Operating Income growth rate?
Operating Income CAGR 5Y
52%

Over the last year, the Operating Income growth was 27%. The average annual Operating Income growth rates for Progyny Inc have been 25% over the past three years , 52% over the past five years .

Back to Top